ROC curves were calculated to evaluate the overall ability of serum NFL and NFH levels to (a) identify patients with MND from other neurological diseases and healthy controls, and (b) identify patients with ALS from those with PMA and PLS. This evidence concerns the gene NEFL and mild neurocognitive disorder.